Skip to main content

Table 4 Serum urate (sUA) and serum creatinine (SCr) results - febuxostat vs. allopurinol- overall propensity-matched population (n = 3,864)

From: Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort

sUA/SCr laboratory results

Total

Febuxostat

Allopurinol

Febuxostat vs. allopurinol

(N = 3,864)

(N = 1,932)

(N = 1,932)

P value

 

N (%)

Mean (SD)

N (%)

Mean (SD)

N (%)

Mean (SD)

 

Pre-index sUA result

2,137 (55.3)

 

1,082 (56.0)

 

1,055 (54.6)

 

0.38

  Number of sUA results

 

1.3 (0.7)

 

1.4 (0.8)

 

1.2 (0.5)

<0.001

  Final sUA result

 

8.3 (2.1)

 

8.4 (2.2)

 

8.3 (2.0)

0.70

  Average sUA result

 

8.4 (1.9)

 

8.5 (1.9)

 

8.4 (1.9)

0.06

Pre-index SCr result

2,298 (59.5)

 

1,151 (59.6)

 

1,147 (59.4)

 

0.90

  Number of SCr results

 

1.7 (1.3)

 

1.7 (1.2)

 

1.6 (1.4)

0.02

  Final SCr result

 

1.3 (0.6)

 

1.4 (0.6)

 

1.3 (0.6)

0.003

  Average SCr result

 

1.3 (0.6)

 

1.4 (0.6)

 

1.3 (0.6)

0.001

Post-index sUA result

3,864 (100)

 

1,932 (100)

 

1,932 (100)

 

–

  Number of sUA results

 

2.0 (1.6)

 

2.1 (1.7)

 

1.8 (1.5)

<0.001

  Average sUA result

 

6.5 (1.8)

 

6.4 (2.0)

 

6.6 (1.7)

<0.001

Post-index SCr result

3,492 (90.4)

 

1,747 (90.4)

 

1,745 (90.3)

 

0.91

  Number of SCr results

 

3.1 (3.3)

 

3.2 (3.1)

 

3.1 (3.4)

0.16

  Average SCr result

 

1.3 (0.6)

 

1.3 (0.6)

 

1.2 (0.6)

<0.001

Proportion with and the time to target sUA achievement

Post-index sUA goal (<6.0 mg/dL)

2,039 (52.8)

 

1,130 (58.5)

 

909 (47.1)

 

<0.001

Time to sUA goal <6.0 mg/dL (days)

 

379 (339)

 

348 (319)

 

410 (355)

<0.001

Post-index sUA goal (<5.0 mg/dL)

1,120 (29.0)

 

699 (36.2)

 

421 (21.8)

 

<0.001

Time to sUA goal <5.0 mg/dL (days)

 

472 (354)

 

443 (332)

 

501 (372)

<0.001

  1. SD, standard deviation.